Display search results for ** instead (123 products)
09 Jan 2020  |  North America
New Age Technology Poised to Change the Way Care is Delivered
The cardiac monitoring market is at a juncture where classical point-of-care monitoring devices are being commoditized, while advances in the understanding of patient needs have resulted in upgraded versions of cardiac monitors entering the market. The classical point-of-care electrocardiogram, as a technology, is at a stage where innovation is foc...
10 Jan 2020  |  North America
A Decade of Change for Healthcare—Access to Key Predictions and Growth Opportunities
Amid rising global trade tensions and sluggish global economic outlook for 2020, the global healthcare market is expected to cross the $2 trillion mark in 2020. Healthcare will be among the top two priorities for voters in the 2020 presidential election in the US. In the European region, looming BREXIT indecision is likely to have a strong impact o...
10 Jan 2020  |  Asia Pacific
Expedited Regulatory Reviews, Accompanied by Surging Novel Drug Pipelines and a Realigned Distribution System will Propel the Chinese Pharma Industry
With over-4000 pharmaceutical players, China is the second largest pharmaceutical industry globally. Although highly fragmented, global pharma and biopharmaceutical players such as Novartis, Novo Nordisk, and AstraZeneca, have a significant hold capturing at least 8-10Percentage of the market. The market being highly dependent on its distributor ne...
USD 8,500.00 save 15 %
21 Jan 2020  |  North America
The Market is Underpenetrated but has the Potential to Reach $9.4 Billion by 2024
Femtech is an emerging term and, as is the case with most new concepts, is poorly understood. While some relate Femtech only with products unique to the female anatomy (including consumer products), others dismiss it as just another term for a group of existing solutions. Frost & Sullivan believes it is a unique space and a place for new growth opp...
24 Jan 2020  |  Global
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) comprises groundbreaking advances across breast cancer screening, next generation sequencing, proteomics, and digital health platforms. The TOE also provides insights across innovative immunotherapy and precision medicine strategies. The Life Science, Health &...
USD 807.50 save 15 %
27 Jan 2020  |  Global
Growth Opportunities—Contract Manufacturing and Outsourcing Opportunities in the In-vitro Diagnostics (IVD) Industry, 2019 to 2022
Consolidation and Innovative Business Models Will Accelerate IVD Outsourcing Growth
The increasing pressure for cost-driven development and regulatory and regional trends are inducing industry participants to adopt innovative integrated business models so as to align themselves as one-stop-shop solution providers as opposed to the traditional functional service providers, thereby, creating a mutually beneficial symbiotic relations...
28 Jan 2020  |  North America
Competitive Dynamics are Pushing Services to the Forefront
Cloud computing in healthcare is gaining momentum as a variety of factors create a significant need for the value propositions that a successful cloud implementation promises to offer. Global healthcare cloud market revenue is expected to surge at a compound annual growth rate of 25.1% from 2018 to 2023. Cloud computing involves the use of exter...
30 Jan 2020  |  North America
The Next Generation RCM is Prioritizing Consumer Centricity
This study primarily strives to: • Analyze the market forces affecting the utilization of next-generation Revenue Cycle Management (RCM) IT and service solutions among US hospitals and physician practices. • Evaluate the latest regulatory objectives that mandate episodic financial risk management initiatives. • Highlight the best ...
31 Jan 2020  |  South Asia, Middle East & North Africa
Pharmaceuticals and Digital Health Account for Around 75% of Revenue and Drive Growth
GCC accounts only for 1.2% of the global HC revenue, but it is the region that saw the highest growth rate in the last decade. GCC has opened doors to global suppliers and moved beyond US imports, which is likely to be the game changer in the 2020s. Technology and digitization are in higher demand than ever before because of higher awareness and ...
31 Jan 2020  |  North America
COVID-19 Pandemic will Drive New Digital-tech Adoption in Drug Discovery and Testing Services, and Federal Funding will Encourage Stronger Product Pipelines
The growth trajectory of the global life sciences industry has benefited from a combination of novel technologies such as CRISPR-Cas9, microbiome and single-cell, relaxation of entry barriers in markets like China, and better-defined regulatory frameworks around next-generation therapies and companion diagnostics. A common denominator of growth a...
USD 1,275.00 save 15 %